EMvision Medical Devices (ASX:EMV) ROCE %: -43.04% (As of Dec. 2025)


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
33 GF Score
Price A$1.52
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices ROCE %?

EMvision Medical Devices ASX:EMV +2.36% 33 ROCE % is -43.04% as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EMvision Medical Devices's annualized ROCE % for the quarter that ended in Dec. 2025 was -43.04%.

EMvision Medical Devices  (ASX:EMV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EMvision Medical Devices ROCE % Related Terms

EMvision Medical Devices ROCE % Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices ROCE % Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial -106.21 -67.96 -58.40 -14.72 -49.67

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.37 -35.11 -31.54 -68.53 -43.04
ASX:EMV
33GF Score
EMvision Medical Devices Ltd ASX:EMV
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices ROCE % Calculation

EMvision Medical Devices's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-8.267/( ( (23.971 - 3.414) + (15.575 - 2.843) )/ 2 )
=-8.267/( (20.557+12.732)/ 2 )
=-8.267/16.6445
=-49.67 %

EMvision Medical Devices's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-7.718/( ( (15.575 - 2.843) + (24.945 - 1.813) )/ 2 )
=-7.718/( ( 12.732 + 23.132 )/ 2 )
=-7.718/17.932
=-43.04 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -43.04% mean?
EMvision Medical Devices (ASX:EMV) has a ROCE % of -43.04% as of Dec. 2025.
Is EMvision Medical Devices' ROCE % too high?
EMvision Medical Devices' current ROCE % is -43.04%. Overall, EMvision Medical Devices has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' ROCE % compare to ABT and SYK?
EMvision Medical Devices' ROCE % of -43.04% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EMvision Medical Devices's current ROCE % is -43.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current ROCE % of -43.04%. The current ROCE % is -43.04%. EMvision Medical Devices' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current ROCE % is -43.04% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
33GF Score

Get the complete analysis for ASX:EMV

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.52
Price